Combined 70- and 80-gene signatures identify tumors with genomically luminal biology responsive to neoadjuvant endocrine therapy and are prognostic of 5-year outcome in early-stage breast cancer

Autor: Pellicane, James V., Beitsch, Peter D., Rock, David T., Budway, Raye J., Dul, Carrie L., Kelemen, Pond R., Ashikari, Andrew Y., Baron, Paul L., Weinstein, Paul D., Mislowsky, Angela, Lee, Laura A., Beatty, Jennifer, Murray, Mary K., Dupree, Beth B., Finn, Christine, Corcoran, Kate, Wang, Shiyu, Menicucci, Andrea R., Yoder, Erin B., Blumencranz, Lisa E., Dauer, Patricia, Audeh, William, Whitworth, Pat W.
Zdroj: In Surgical Oncology December 2022 45
Databáze: ScienceDirect
Externí odkaz: